Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Randall K. Pearson

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5088080468. Sources: ClinicalTrials.gov.

Their work

Papers
7
Trials
1
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

1997: 1 trial · 1998: none · 1999: none · 2000: none · 2001: none · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Safety and Diagnostic Performance of Pancreatic Duct Brushings for Detecting Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002714↗
  2. Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance. Co-author DOI 10.1016/j.gastha.2022.07.004↗
  3. Determining age and sex-specific distribution of pancreatic whole-gland CT attenuation using artificial intelligence aided image segmentation: Associations wit… Co-author DOI 10.1016/j.pan.2021.08.004↗
  4. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Canc… Co-author DOI 10.1038/s41395-018-0403-2↗
  5. Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.01.049↗
  6. Endoscopic Ultrasound Fine-Needle Aspiration Diagnosis of Synchronous Primary Pancreatic Adenocarcinoma and Effects on Staging and Resectability. Co-author DOI 10.1016/j.cgh.2016.08.009↗
  7. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.gie.2014.12.036↗

Trials 1

  1. Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas Study chair NCT00003049↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Santhi Swaroop Vege · 7 shared papers, 2015–2026 · strength 0.72
  2. Shounak Majumder · 4 shared papers, 2019–2026 · strength 0.55
  3. Suresh T. Chari · 6 shared papers, 2015–2022 · strength 0.48
  4. Michael J. Levy · 6 shared papers, 2015–2022 · strength 0.48
  5. Vinay Chandrasekhara · 3 shared papers, 2021–2026 · strength 0.47
  6. Ferga C. Gleeson · 5 shared papers, 2015–2022 · strength 0.41
  7. Michael L. Kendrick · 3 shared papers, 2017–2022 · strength 0.26
  8. Naoki Takahashi · 3 shared papers, 2018–2021 · strength 0.25
  9. Mark D. Topazian · 4 shared papers, 2015–2019 · strength 0.25
  10. Motaz H. Ashkar · 1 shared paper, 2026 · strength 0.24
  11. Shuji Mitsuhashi · 1 shared paper, 2026 · strength 0.24
  12. Eric J. Vargas · 1 shared paper, 2026 · strength 0.24
  13. Lizhi Zhang · 2 shared papers, 2019–2022 · strength 0.20
  14. Mark Joseph Truty · 2 shared papers, 2017–2022 · strength 0.18
  15. Jaime de la Fuente · 1 shared paper, 2022 · strength 0.12
  16. Sean Patrick Cleary · 1 shared paper, 2022 · strength 0.12
  17. Rondell Patrell Graham · 1 shared paper, 2022 · strength 0.12
  18. Arjun Chatterjee · 1 shared paper, 2022 · strength 0.12
  19. Laurens P. Janssens · 1 shared paper, 2021 · strength 0.11
  20. Dhruv Pratap Singh · 1 shared paper, 2021 · strength 0.11
  21. Kenneth K. Wang · 2 shared papers, 2015–2017 · strength 0.10
  22. Thomas C. Smyrk · 1 shared paper, 2019 · strength 0.08
  23. Sajan Jiv Singh Nagpal · 1 shared paper, 2019 · strength 0.08
  24. Ayush Sharma · 1 shared paper, 2018 · strength 0.07
  25. Saurabh S. Mukewar · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.